Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|September 1, 2015
Data Warehousing and Specialty Pharmacy
Author(s)Davy James, Managing Editor
Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.
Advertisement
Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.
Advertisement
Related to this article
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Apitegromab-mstn is cleared as an add-on to SMN2-targeted treatment for patients aged 2 and older, directly addressing muscle loss.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5